Despite negative perceptions of clinical trial conduct during the coronavirus disease 2019 (COVID-19) pandemic, are decentralized clinical trial methods here to stay?
Ann Transl Med
.
2023 Feb 28;11(4):159.
doi: 10.21037/atm-23-5.
Epub 2023 Feb 6.
Authors
Lisa Cooper
1
,
Nadina Jose
1
Affiliation
1
Department of Health Informatics, School of Health Professions, Rutgers, The State University of New Jersey, Newark, NJ, USA.
PMID:
36923074
PMCID:
PMC10009564
DOI:
10.21037/atm-23-5
No abstract available
Keywords:
Coronavirus disease 2019 (COVID-19); decentralized clinical trials; pandemic; perceptions.
Publication types
Editorial
Comment